Research Investigator in Biochemistry
Submitted by admin on Tue, 03/15/2011 - 16:09
We are seeking research investigators in the biochemistry group to support drug discovery efforts for the treatment of cancer.
The primary responsibilities are design and execute experiments to understand the biochemistry of the therapeutic target, develop and validate biochemical assays and investigate the mechanism of action of the drug candidates. This candidate is expected to present and communicate internally and to collaborators. This candidate will also be supervising a group of 2-4 research scientists.
The primary responsibilities are design and execute experiments to understand the biochemistry of the therapeutic target, develop and validate biochemical assays and investigate the mechanism of action of the drug candidates. This candidate is expected to present and communicate internally and to collaborators. This candidate will also be supervising a group of 2-4 research scientists.
Basic Qualifications
¡¤ A Ph.D degree in biochemistry with 0-3 years experience in drug discovery
¡¤ Demonstrated problem solving skills and record of scientific innovation
¡¤ Experience in biochemical assay development, mechanistic biochemistry and/or HTS
¡¤ Excellent analytical and organizational skills
¡¤ Good oral and written communications skills in English
Preferred Qualifications
¡¤ Experience in the oncology biology
¡¤ Experience in managing scientists in a research organization
¡¤ Expertise in assay development (TR-FRET, FP, SPA, fluorescence) and mechanistic biochemistry techniques
¡¤ Biophysics background with experience in Biacore, ITC or other biophysical analysis
¡¤ Communication ability in Chinese strongly preferred.
About BeiGene
BeiGene is a fully integrated biotechnology company based in Beijing that is focused on discovering and developing innovative oncology drugs. Our compound portfolio will encompass novel drugs that evolve out of our discovery laboratories in China and those selected from in-licensing partners for their potential to have high impact in the treatment of Chinese and Asian cancers.
To complement our discovery and development capabilities, BeiGene is creating a robust platform in China to enable the identification of specific subsets of patient populations that will identify patients who are most likely to benefit from the use of specific drugs or treatments. Understanding the link between treatment sensitivity and molecular targets will direct us to develop future drug candidates with greater efficacy and safety.
We are building core excellence in:
•novel drug discovery in the areas of both small molecules and biologicals
•translational research with an emphasis on biomarker identification and validation in patients
•bioinformatics based on human tumor genotyping and expression profiling
•clinical development
We are recruiting scientists who are passionate about research and innovation and who have the entrepreneurial spirit to build a lasting organization in China known for its impact on cancer.
Source::
Internet